y Cochrane Rapid Review: The Immune Checkpoint Inhibitor Pembrolizumab versus Chemotherapy for the Treatment of advanced Urothelial Carcinoma

被引：0
|
作者：
Wilborn, D. [1 ]
Schmidt, S. [1 ]
机构：
[1] UroEvidence Deutsch Gesell Urol, Nestorstr 8-9, D-10709 Berlin, Germany
来源：
UROLOGE | 2019年 / 58卷 / 01期
关键词：
BACILLUS-CALMETTE-GUERIN; MULTICENTER; THERAPY;
D O I：
10.1007/s00120-018-0838-5
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：45 / 48
页数：4
相关论文
共 50 条
  • [1] Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review
    Narayan, Vikram
    Kahlmeyer, Andreas
    Dahm, Philipp
    Skoetz, Nicole
    Risk, Michael C.
    Bongiorno, Connie
    Patel, Neil
    Hwang, Eu Chang
    Jung, Jae Hung
    Gartlehner, Gerald
    Kunath, Frank
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (07):
  • [2] The efficacy of immune checkpoint inhibitors therapy versus chemotherapy in the treatment of advanced and metastatic urothelial carcinoma: a meta-analysis
    Huang, Gaozhen
    Xiong, Hong
    Li, Shihao
    Zhu, Yi
    Liu, Hongwei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (01)
  • [3] Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Makrakis, Dimitrios
    Bakaloudi, Dimitra Rafailia
    Talukder, Rafee
    Lin, Genevieve Ihsiu
    Diamantopoulos, Leonidas N.
    Jindal, Tanya
    Vather-Wu, Naomi
    Zakharia, Yousef
    Tripathi, Nishita
    Agarwal, Neeraj
    Dawsey, Scott
    Gupta, Shilpa
    Lu, Eric
    Drakaki, Alexandra
    Liu, Sandy
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Fulgenzi, Claudia -Maria
    Cortellini, Alessio
    Pinato, David
    Barata, Pedro
    Grivas, Petros
    Khaki, Ali Raza
    Koshkin, Vadim S.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 286 - 294
  • [4] TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma
    Nishiyama, Hiroyuki
    Yonese, Junji
    Kawahara, Takashi
    Matsumoto, Ryuji
    Miyake, Hideaki
    Matsubara, Nobuaki
    Uemura, Hiroji
    Eto, Masatoshi
    Azuma, Haruhito
    Obara, Wataru
    Terai, Akito
    Fukasawa, Satoshi
    Suekane, Shigetaka
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (04) : 532 - 540
  • [5] Differential impact of proton pump inhibitor on survival outcomes of patients with advanced urothelial carcinoma treated with chemotherapy versus pembrolizumab
    Tomisaki, Ikko
    Harada, Mirii
    Sakano, Shigeru
    Terado, Michikazu
    Hamasuna, Ryoichi
    Harada, Shuji
    Matsumoto, Hiroomi
    Akasaka, Soichiro
    Nagata, Yujiro
    Minato, Akinori
    Harada, Ken-ichi
    Fujimoto, Naohiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (09) : 738 - 745
  • [6] Treatment options for advanced urothelial cancer after progression on chemotherapy and immune checkpoint inhibitors: a literature review
    Koshkin, Vadim S.
    Osbourne, Appledene S.
    Grivas, Petros
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (10) : 4022 - 4035
  • [7] Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma
    Meynard, Lucie
    Dinart, Derek
    Delaunay, Blandine
    Flechon, Aude
    Saldana, Carolina
    Lefort, Felix
    Gravis, Gwenaelle
    Thiery-Vuillemin, Antoine
    Cancel, Mathilde
    Coquan, Elodie
    Ladoire, Sylvain
    Maillet, Denis
    Rolland, Frederic
    Boughalem, Elouen
    Martin, Sophie
    Laramas, Mathieu
    Crouzet, Laurence
    Abbar, Baptiste
    Falkowski, Sabrina
    Pouessel, Damien
    Roubaud, Guilhem
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : 43 - 53
  • [8] A Review of Immune Checkpoint Inhibitors for the Management of Locally Advanced or Metastatic Urothelial Carcinoma
    Hanna, Kirollos S.
    PHARMACOTHERAPY, 2017, 37 (11): : 1391 - 1405
  • [9] Recent advances in immune checkpoint inhibitors in the treatment of urothelial carcinoma: A review
    Kato, Minoru
    Uchida, Junji
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (12) : 1068 - 1077
  • [10] The Evolution of Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Houssiau, Helene
    Seront, Emmanuel
    CANCERS, 2022, 14 (07)
12345